ZEJULA
Identification of Zejula
No description |
Google image searchProduct monograph
Active ingredient
niraparib (niraparib tosylate), 100 MG
DIN: 02489783
Dosage form(s): CAPSULE
Route(s) of administration: ORAL
Schedule: Prescription
Company: GLAXOSMITHKLINE INC
Date: 09-JAN-2020
ATC:
- L01 — ANTINEOPLASTIC AGENTS (ATC, ATC/DDD, )
- L01X — OTHER ANTINEOPLASTIC AGENTS (ATC, ATC/DDD)
- L01XK — Poly (ADP-ribose) polymerase (PARP) inhibitors (ATC, ATC/DDD)
- L01XK02 — NIRAPARIB (ATC/DDD)
External Links for Zejula
Search on Google
Glaxosmithkline Inc
Go to GlaxoSmithKline website to see drug product details. Sometimes you can find zejula photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.